SpyBiotech, which makes a ‘superglue’ for vaccines, raises £4M from GV and Oxford

 The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue” — coincidentally, for bug-combatting vaccines. SpyBiotech — a startup spun out of Oxford University that has developed way to bond antigens to viruses and other particles to make vaccines — has announced £4 million ($5 million) in funding… Read More

from https://techcrunch.com/2017/03/30/spybiotech-which-makes-superglue-for-vaccines-raises-4m-from-gv-and-oxford/?ncid=rss